Jon Duke
Cited by
Cited by
Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers
G Hripcsak, JD Duke, NH Shah, CG Reich, V Huser, MJ Schuemie, ...
Studies in health technology and informatics 216, 574, 2015
Generating multi-label discrete patient records using generative adversarial networks
E Choi, S Biswal, B Malin, J Duke, WF Stewart, J Sun
Machine learning for healthcare conference, 286-305, 2017
Characterizing treatment pathways at scale using the OHDSI network
G Hripcsak, PB Ryan, JD Duke, NH Shah, RW Park, V Huser, MA Suchard, ...
Proceedings of the National Academy of Sciences 113 (27), 7329-7336, 2016
Explainable prediction of medical codes from clinical text
J Mullenbach, S Wiegreffe, J Duke, J Sun, J Eisenstein
arXiv preprint arXiv:1802.05695, 2018
Defining a reference set to support methodological research in drug safety
PB Ryan, MJ Schuemie, E Welebob, J Duke, S Valentine, AG Hartzema
Drug safety 36 (1), 33-47, 2013
Literature Based Drug Interaction Prediction with Clinical Assessment Using Electronic Medical Records: Novel Myopathy Associated Drug Interactions
JD Duke, X Han, Z Wang, A Subhadarshini, SD Karnik, X Li, SD Hall, ...
PLoS Computational Biology 8 (8), e1002614, 2012
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis
MA Suchard, MJ Schuemie, HM Krumholz, SC You, RJ Chen, N Pratt, ...
The Lancet 394 (10211), 1816-1826, 2019
Adherence to drug–drug interaction alerts in high-risk patients: a trial of context-enhanced alerting
J Duke, X Li, D P
Journal of the American Medical Informatics Association, 2012
A quantitative analysis of adverse events and “overwarning” in drug labeling
J Duke, J Friedlin, P Ryan
Archives of internal medicine 171 (10), 941-954, 2011
ADESSA: a real-time decision support service for delivery of semantically coded adverse drug event data
JD Duke, J Friedlin
AMIA Annual symposium proceedings 2010, 177, 2010
A successful model and visual design for creating context-aware drug-drug interaction alerts
JD Duke, D Bolchini
AMIA Annual Symposium Proceedings 2011, 339, 2011
Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest
RD Boyce, PB Ryan, GN Norén, MJ Schuemie, C Reich, J Duke, ...
Drug safety 37 (8), 557-567, 2014
Development and preliminary evidence for the validity of an instrument assessing implementation of human-factors principles in medication-related decision-support systems—I-MeDeSA
M Zachariah, S Phansalkar, HM Seidling, PM Neri, KM Cresswell, J Duke, ...
Journal of the American Medical Informatics Association 18 (Supplement_1 …, 2011
Consistency in the safety labeling of bioequivalent medications
J Duke, J Friedlin, X Li
Pharmacoepidemiology and drug safety 22 (3), 294-301, 2013
Data visualization speeds review of potential adverse drug events in patients on multiple medications
JD Duke, X Li, SJ Grannis
Journal of biomedical informatics 43 (2), 326-331, 2010
Supporting clinical cognition: a human-centered approach to a novel ICU information visualization dashboard
A Faiola, P Srinivas, J Duke
AMIA Annual Symposium Proceedings 2015, 560, 2015
Regenstrief Institute's medical gopher: A next-generation homegrown electronic medical record system
JD Duke, J Morea, B Mamlin, DK Martin, L Simonaitis, BY Takesue, ...
International journal of medical informatics 83 (3), 170-179, 2014
Multisite evaluation of a data quality tool for patient-level clinical data sets
V Huser, FJ DeFalco, M Schuemie, PB Ryan, N Shang, M Velez, RW Park, ...
EGEMs 4 (1), 2016
Speaking the same language? International variations in the safety information accompanying top-selling prescription drugs
AS Kesselheim, JM Franklin, J Avorn, JD Duke
BMJ quality & safety 22 (9), 727-734, 2013
Is big data the new frontier for academic-industry collaboration?
SH Jain, M Rosenblatt, J Duke
Jama 311 (21), 2171-2172, 2014
The system can't perform the operation now. Try again later.
Articles 1–20